CIMS Medica held the 9th edition of Business Excellence Awards

CIMS Medica held the 9th edition of Business Excellence Awards to appreciate and applaud companies whose contribution to the growth and development in the Healthcare and Pharmaceutical industry was commendable.

This year the award ceremony was held on 18th December 2020 at the magnificent The Leela Palace Hotel, New Delhi, under complete government-issued safety guidance for COVID-19.

The 9th edition of Business Excellence Awards provided a common platform to all companies from the Healthcare and Pharmaceutical Industry, recognizing their innovation and dedication to deliver better healthcare service.

The event experienced the presence of key dignitaries and VIPs from the industry. Mr. Amarjeet Singh Cheema, Joint Director C-DAC – Head of the Department of Health Informatics Group, CDAC, Noida, was the guest of honor who presented the awards to the winning companies along with Dr. Monica Sood Bhatia, Managing Director, CIMS Medica.

In this year’s grand edition, companies around India took active participation. Interestingly, the companies that won awards were from different fields under the Healthcare and Pharmaceutical industry. The companies like Ethnic Biotech, Samson Laboratories Pvt Ltd, L&T Technology services & Agappe Diagnostics Ltd, Medanta – The Medicity, Sunesta Lifesciences, Triangle Print Communication, SYNOX (A division of Lupin), Zee Lab Pharmacy, GLUCONORM-G, Telista, CHILKUL (Aptus Pharma), Mishkon Research Labs Ltd, Lakshmi Prints, and Bluestar Laboratories were applauded and took awards home.

The 9th Edition of Business Excellence Awards witnessed success in recognizing the participants from the industry and boosting their spirits.

Related Posts

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

New Delhi:  Indian researchers have developed an experimental “smart” cancer drug designed to remain largely inactive in healthy tissues and activate primarily inside cancer cells, potentially reducing the severe side…

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions